{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:10:03Z","timestamp":1756289403834,"version":"3.44.0"},"reference-count":13,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,3,29]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Flecainide is a class 1C antiarrhythmic, which is known to cause several cardiac and non-cardiac adverse reactions. We report a case of a 62-year-old woman with atrial fibrillation who presented with generalised myalgias and intermittent chest heaviness after being started on flecainide. She had undergone her third cardiac ablation 1\u2009week prior to presentation and was subsequently started on flecainide 150 mg two times per day. On physical examination, she had diminished reflexes and diffuse calf tenderness. Her blood tests demonstrated an increased erythrocyte sedimentation rate and C reactive protein, but otherwise normal infectious and autoimmune labs. Her ECG showed normal sinus rhythm. A Naranjo score of 7 suggested flecainide as a probable cause of her myalgias. The patient\u2019s symptoms started to normalise within 24 hours of discontinuation of flecainide. Our case highlights that myalgias are a potential rare adverse effect that should be considered in patients prescribed flecainide.<\/jats:p>","DOI":"10.1136\/bcr-2020-238699","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T13:02:14Z","timestamp":1618491734000},"page":"e238699","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Flecainide-induced myalgias and weakness: a rare adverse reaction"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8462-4627","authenticated-orcid":false,"given":"Dilpat","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ebad","family":"Rehman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey","family":"Mersfelder","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Ferris State University, Big Rapids, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"2025082702525902000_14.4.e238699.1","doi-asserted-by":"crossref","first-page":"83A","DOI":"10.1016\/S0002-9149(97)89122-9","article-title":"Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia","volume":"77","author":"Hellestrand","year":"1996","journal-title":"Am J Cardiol"},{"key":"2025082702525902000_14.4.e238699.2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/WNF.0000000000000025","article-title":"Flecainide-induced myoclonus","volume":"37","author":"Velasco","year":"2014","journal-title":"Clin Neuropharmacol"},{"key":"2025082702525902000_14.4.e238699.3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.CIR.83.1.345","article-title":"Flecainide acetate for long-term prevention of paroxysmal supraventricular tachyarrhythmias","volume":"83","author":"Benditt","year":"1991","journal-title":"Circulation"},{"key":"2025082702525902000_14.4.e238699.4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/mus.22239","article-title":"Skin biopsy-proven flecainide-induced neuropathy","volume":"45","author":"Burakgazi","year":"2012","journal-title":"Muscle Nerve"},{"key":"2025082702525902000_14.4.e238699.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103213241201"},{"key":"2025082702525902000_14.4.e238699.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198908103210629"},{"key":"2025082702525902000_14.4.e238699.7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0003-3928(02)00183-X","article-title":"Safety of a controlled-release flecainide acetate formulation in the prevention of paroxysmal atrial fibrillation in outpatients","volume":"52","author":"Aliot","year":"2003","journal-title":"Ann Cardiol Angeiol"},{"key":"2025082702525902000_14.4.e238699.8","doi-asserted-by":"publisher","DOI":"10.2165\/11599950-000000000-00000"},{"key":"2025082702525902000_14.4.e238699.9","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90511-3"},{"key":"2025082702525902000_14.4.e238699.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(10)80090-7"},{"key":"2025082702525902000_14.4.e238699.11","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"2025082702525902000_14.4.e238699.12","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G036"},{"key":"2025082702525902000_14.4.e238699.13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.3.340"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-238699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:53:09Z","timestamp":1756288389000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-238699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,15]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bcr-2020-238699"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-238699","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}